Mirina Changes Name to Groove Biopharma | GenomeWeb

By Doug Macron

Mirina this week announced that it has changed its name to Groove Biopharma in a move it said will better reflect the company's core technology, a novel miRNA-inhibition platform based on minor groove binders.

The name change also happens to come on the heels of Mirina's failed bid to sue Marina Biotech for trademark infringement due to its similar-sounding name.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

The Nuffield Council on Bioethics identifies ethical questions to explore surrounding genome editing.

In a blog post, Brigham and Women's Hospital's Robert Green discusses "predispositional personal genome sequencing."

Stat News reports that there's muted opposition to the Kuwaiti DNA database law.

In Science this week: global genetic diversity map, and more.